PHE's Lakdawalla in LA Times: Providing Perspective on California's Proposed Single-Payer Plan

PHE Co-founder and Chief Scientific Officer Darius Lakdawalla speaks with Melanie Mason from The Los Angeles Times in a new Q&A, discussing the implications of California’s new legislation favoring a single-payer healthcare system.

To read the complete article, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.